Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004989787 | SCV005600645 | uncertain significance | Inborn genetic diseases | 2024-11-08 | criteria provided, single submitter | clinical testing | The c.3901G>A (p.E1301K) alteration is located in exon 28 (coding exon 27) of the ABCB11 gene. This alteration results from a G to A substitution at nucleotide position 3901, causing the glutamic acid (E) at amino acid position 1301 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |